State University of New York (SUNY)·New York

Chimeric Antigen Receptor (CAR) T-Cell Therapy System

Closes 2/2/2026$1.5M – $3MSole SourceLogin required

Bid source

Description

CRER-ID: SNY01-0004321-3320215

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Robert Meyn(Sr Procurement Officer)

[email protected]

(631) 444-4068

Key dates

Opened: 1/9/2026
Closes: 2/2/2026
Duration: 1095 days

Last updated

Details

Type: Sole Source
Industry: Healthcare and Medical Services
NAICS: 325414
Solicitation №: 2130366

Budget estimate

$1,500,000 – $3,000,000

The budget for this contract can be estimated based on the contract term and the type of system being procured. Since the contract term is approximately 3 years, and the system is a specialized medical equipment, the budget could be substantial. Assuming an average annual cost of $500,000 to $1,000,000 for the system and maintenance, the total budget for the contract term could be in the range of $1,500,000 to $3,000,000. This is a rough estimate and the actual budget could be higher or lower, depending on the specifics of the contract and the system being procured.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+

bids & awards

All 50

states

4,000+

agencies

Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

Learn more

More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →

Description

Attached files

Contact

Similar opportunities

You found this one too late. Don't find the next one too late.

Learn more

Description

Attached files

Contact

Similar opportunities

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Immune Tolerance Network (UM1 Clinical Trial Required)

Translational Transplantation Tolerance Cooperative Study Group

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Pre-Clinical Models of Infectious Diseases

The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

Clinical Trials in Organ Transplantation in Children and Adults

National Biomedical Research Centers (P50 Clinical Trial Optional)

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

Immune Drivers of Autoimmune Disease

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

ITB: Vehicle Purchase for Mobile Integrated Healthcare (MIH) Community Paramedic (Re-Advertisement)

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

6640--LAB - Immunochemistry (IHC) STAIN system CPT

RFP 739-SL3838039 Turnkey Mobile Telehealth and Command Center Vehicle

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

CDC Technical Assistance for Program Implementation, Messaging, Evaluation, and Translation Services in Support of Nutrition, Physical Activity, and Obesity Prevention

Microbial Identification System (MIS)

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

You found this one too late. Don't find the next one too late.

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Immune Tolerance Network (UM1 Clinical Trial Required)

Translational Transplantation Tolerance Cooperative Study Group

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Pre-Clinical Models of Infectious Diseases

The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes

Clinical Trials in Organ Transplantation in Children and Adults

National Biomedical Research Centers (P50 Clinical Trial Optional)

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

Immune Drivers of Autoimmune Disease

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

ITB: Vehicle Purchase for Mobile Integrated Healthcare (MIH) Community Paramedic (Re-Advertisement)

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

6640--LAB - Immunochemistry (IHC) STAIN system CPT

RFP 739-SL3838039 Turnkey Mobile Telehealth and Command Center Vehicle

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

CDC Technical Assistance for Program Implementation, Messaging, Evaluation, and Translation Services in Support of Nutrition, Physical Activity, and Obesity Prevention

Microbial Identification System (MIS)

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)